Medvarsity Logo
Intrahepatic  Cholestasis of Pregnancy : An Overview & Update

CASE DISCUSSION

Intrahepatic Cholestasis of Pregnancy : An Overview & Update

United Arab Emirates flagPresented United Arab Emirates by Dr. Krishi Gowdra

Views

74,776

Case Description

Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that occurs during pregnancy, characterized by impaired bile flow and elevated levels of bile acids in the bloodstream. The exact cause of ICP is not fully understood, but hormonal changes, genetic predisposition, and environmental...

Case Summary

  • Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder characterized by generalized pruritus without skin lesions, elevated serum bile acids, typically developing in the second or third trimester, and resolving rapidly postpartum. Incidence varies globally, with higher rates in certain ethnic groups. Obstetricians must understand ICP management to minimize stillbirth risk.

Speaker Profile

Dr. Krishi Gowdra

Dr. Krishi Gowdra

M.B.B.S, MS, MRCOG Specialist in OBG at Zulekha Hospital Dubai
Dr. Krishi Gowdra is a Specialist in Obstetrics and Gynecology at Zulekha Hospital. She holds MBBS, MS, and MRCOG qualifications, reflecting advanced training and expertise in women’s health and reproductive medicine. Her clinical interests include antenatal care, high-risk pregnancies, gynecological disorders, preventive women’s healthcare, and minimally invasive gynecological procedures. She is committed to providing compassionate, evidence-based care tailored to the unique needs of women across all stages of life. Through her clinical practice, she continues to contribute to advancing maternal and women’s healthcare in the UAE.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.